Athira Pharma Inc (OQ:ATHA)

Business Focus: Biotechnology & Medical Research

Latest 10 SEC filings (by transaction date) for ATHA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 12th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Apr 16/24 Apr 15/24 San Martin Javier Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 400,000  
Feb 16/24 Feb 15/24 Litton Mark James Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 650,000  
Feb 16/24 Feb 14/24 Worthington Mark Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 220,000  
Feb 16/24 Feb 14/24 Church Kevin Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 220,000  
Feb 16/24 Feb 14/24 Gengos Andrew Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 280,000  
Feb 16/24 Feb 14/24 Lenington Rachel Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 300,000  
Feb 16/24 Jan 5/24 Lenington Rachel Direct Ownership Common Stock S - Open market or private sale -2,412 $2.91
Feb 16/24 Jan 5/24 Litton Mark James Direct Ownership Common Stock S - Open market or private sale -4,820 $2.91
Feb 16/24 Jan 5/24 Worthington Mark Direct Ownership Common Stock S - Open market or private sale -2,412 $2.91
Feb 16/24 Jan 5/24 Gengos Andrew Direct Ownership Common Stock S - Open market or private sale -1,208 $2.91
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ATHA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 12th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Apr 16/24 Apr 15/24 San Martin Javier Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 400,000  
Feb 16/24 Feb 15/24 Litton Mark James Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 650,000  
Feb 16/24 Feb 14/24 Worthington Mark Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 220,000  
Feb 16/24 Feb 14/24 Church Kevin Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 220,000  
Feb 16/24 Feb 14/24 Gengos Andrew Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 280,000  
Feb 16/24 Feb 14/24 Lenington Rachel Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 300,000  
Feb 16/24 Jan 5/24 Lenington Rachel Direct Ownership Common Stock S - Open market or private sale -2,412 $2.91
Feb 16/24 Jan 4/24 Lenington Rachel Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 10,000  
Feb 16/24 Jan 5/24 Litton Mark James Direct Ownership Common Stock S - Open market or private sale -4,820 $2.91
Feb 16/24 Jan 4/24 Litton Mark James Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 20,000  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $ATHA

  • No tweets found

Competitors

Competitors with Recent Insider Filings
Medpace Holdings (OQ:MEDP)
United Therapeutics (OQ:UTHR)
Disc Medicine (OQ:IRON)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.